34. Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain JL, De Roo M, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med. 1990;322(15):1028-31. doi: 10.1056/ NEJM199004123221502. 35. Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration. Anesthesiology. 2017;126(3):376-93. doi: 10.1097/ALN.0000000000001452. 36. Meier JJ, Kemmeries G, Holst JJ, Nauck MA. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects. Diabetes. 2005;54(7):2212-8. doi: 10.2337/diabetes.54.7.2212. 37. Jones KL, Berry M, Kong MF, Kwiatek MA, Samsom M, Horowitz M. Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care. 1999;22(2):33944. doi: 10.2337/diacare.22.2.339. ANZCA sq@anzca.edu.au Australian Diabetes Society (ADS) admin@diabetessociety.com.au Gastroenterological Society of Australia (GESA) gesa@gesa.org.au National Association of Clinical Obesity Services (NACOS) info@nacos.org.au Contact participating organisations
Brought to you by digidoc.online
ZGlnaWRvYyBvbmxpbmU=